Estamos no TOP 15 do estudo da Happiness Works e não poderíamos estar mais felizes e orgulhosos com esta conquista.
Ser uma empresa feliz é, para nós, valorizar o bem-estar, promover o espírito de equipa e cooperação e criar condições à felicidade individual dos nossos colaboradores.
Acreditamos que uma empresa feliz é feita de pessoas felizes, realizadas na empresa e nas suas vidas.
Na sequência da notícia publicada pelo jornal Público no dia 17 de maio com o título “Três milhões de máscaras compradas com certificado falso” e replicada por diversos meios de comunicação social, a Quilaban esclarece o seguinte:
Para satisfazer o contrato de fornecimento à Direção Geral de Saúde (DGS), por ajuste direto dos Serviços Partilhados do Ministério da Saúde (SPMS), de três milhões de máscaras FF92 /KN95, a Quilaban recorreu à produção da Gansu Changee Bio-pharmaceutical Co., Ltd. (Gansu).
Taking into account all the difficulties that we need to overcome in order to export the goods, we are very proud to announce that we are implementing our purpose which is to care for the health and well-being of people like us across the border.
Before we had already supplied rapid tests and other products for the diagnostic and fight against COVID-19 in external markets, but now we are also participating actively in this fight in Cape Verde, by means of the supply of 30.000 rapid tests to EMPROFAC.
Last month we were formally awarded the second GeneReader™NGS system in Portugal, at the Centro Hospitalar de Trás os Montes e Alto Douro (CHTMAD), in the city of Vila Real.
This was only possible through hard team work hat reinforces Quilaban’s position in the field of Diagnostics for Oncology.
The NGS Qiagen workflow is designed for clinical diagnostics and aims to give a fast, simple, optimized response with maximum relevant Information to our oncologists.
“Confidence in our path wo the new normal” – With this purpose in mind, we dedicated ourselves to build a complementary solution to the preventive measures against COVID-19 contamination.
Because a rapid test approaches the detection of an infection based upon indications, we can identify asymptomatic persons who are carriers of the disease of potentially immune. In this way we will protect our teams and promote operability and confidence.
We are focused on the satisfaction of our customers’ needs by providing innovative and efficient products and solutions.
In 2019, 718 customers evaluated us, supporting with their opinions and recommendations regarding the quality of our service.
The dynamics of diagnostic based on the identification and interpretation of the genome represents an enormous challenge and encloses a universe of extraordinary responses, through which we will be able to fulfil the purpose that inspires us.
At the Excellence at Work Index Awards Ceremony, we were recognized as a company of excellence in Portugal:
We strengthened our partnership with the big private laboratories, by developing tailor-made solutions for each customer for the detection of SARS-CoV-2.
Together, empowering for SARS-CoV-2 detection
5 Quilaban specialists are carrying out an accelerated introduction and training program of about 50 diagnostics professionals, in four public hospitals, to use BD MAX technology.
The BD MAX equipment is an automated and fully integrated system, which allows the simultaneous management of up to 24 samples to detect the COVID-19, optimizing the time to obtain results.